ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1.


Journal

Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103

Informations de publication

Date de publication:
29 09 2023
Historique:
medline: 2 10 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: ppublish

Résumé

The Targets of ADAMTS-7 were identified by high-resolution mass spectrometry of atherosclerotic plaques from Apoe In humans, ADAMTS-7, which is induced in unstable atherosclerotic plaques, decreases TIMP-1 stability reducing its inhibitory effect on MMP-9, which is known to promote collagen degradation and is likewise associated with coronary artery disease. Disrupting the interaction of ADAMTS-7 and TIMP-1 might be a strategy to increase collagen content and plaque stability for the reduction of atherosclerosis-related events.

Sections du résumé

BACKGROUND
The
METHODS
Targets of ADAMTS-7 were identified by high-resolution mass spectrometry of atherosclerotic plaques from Apoe
RESULTS
In humans,
CONCLUSIONS
ADAMTS-7, which is induced in unstable atherosclerotic plaques, decreases TIMP-1 stability reducing its inhibitory effect on MMP-9, which is known to promote collagen degradation and is likewise associated with coronary artery disease. Disrupting the interaction of ADAMTS-7 and TIMP-1 might be a strategy to increase collagen content and plaque stability for the reduction of atherosclerosis-related events.

Identifiants

pubmed: 37675562
doi: 10.1161/CIRCRESAHA.123.322737
pmc: PMC7615141
mid: EMS187870
doi:

Substances chimiques

ADAMTS7 Protein EC 3.4.24.-
Collagen 9007-34-5
Matrix Metalloproteinase 9 EC 3.4.24.35
Tissue Inhibitor of Metalloproteinase-1 0
ADAMTS7 protein, human EC 3.4.24.-
Adamts7 protein, mouse EC 3.4.24.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

674-686

Subventions

Organisme : European Research Council
ID : 101077205
Pays : International
Organisme : British Heart Foundation
Pays : United Kingdom

Références

N Engl J Med. 2016 Mar 24;374(12):1134-44
pubmed: 26934567
Mol Cell Proteomics. 2018 Feb;17(2):321-334
pubmed: 29208753
Genome Biol. 2011 Nov 11;12(11):233
pubmed: 22078297
Biochem J. 2006 Sep 15;398(3):515-9
pubmed: 16771712
Nat Genet. 2011 Mar 06;43(4):339-44
pubmed: 21378988
JACC Basic Transl Sci. 2021 Jul 26;6(7):610-623
pubmed: 34368511
FEBS Lett. 1998 Sep 11;435(1):39-44
pubmed: 9755855
Circulation. 2015 Mar 31;131(13):1156-9
pubmed: 25712207
Cardiovasc Res. 2016 Feb 1;109(2):318-30
pubmed: 26645981
J Biol Chem. 2004 Aug 20;279(34):35159-75
pubmed: 15192113
Cell Mol Life Sci. 2014 Feb;71(4):659-72
pubmed: 23982756
Circ Res. 2009 Mar 13;104(5):688-98
pubmed: 19168437
Circulation. 2023 Feb 28;147(9):728-742
pubmed: 36562301
Circ Res. 2021 Aug 6;129(4):458-470
pubmed: 34176299
Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2580-8
pubmed: 22995515
Circ Res. 2017 Feb 17;120(4):633-644
pubmed: 27895035
Int J Mol Med. 2011 Aug;28(2):247-53
pubmed: 21567073
Cardiovasc Res. 2009 Jan 1;81(1):178-86
pubmed: 18852254
Circulation. 2006 May 23;113(20):2435-44
pubmed: 16702468
Sci Rep. 2017 Aug 31;7(1):10252
pubmed: 28860667
Circulation. 2015 Mar 31;131(13):1202-1213
pubmed: 25712206
Nat Cell Biol. 2000 Oct;2(10):737-44
pubmed: 11025665
J Biol Chem. 2019 May 17;294(20):8037-8045
pubmed: 30926607
Lancet. 2011 Jan 29;377(9763):383-92
pubmed: 21239051
Circulation. 2021 Nov 9;144(19):1567-1583
pubmed: 34647815
Nat Genet. 2011 Mar 06;43(4):333-8
pubmed: 21378990
Blood. 2013 Dec 12;122(25):4054-67
pubmed: 24174628
J Biol Chem. 1997 Nov 21;272(47):29975-83
pubmed: 9368077
J Biol Chem. 2021 Sep;297(3):101072
pubmed: 34391782
PLoS One. 2017 Feb 6;12(2):e0171427
pubmed: 28166283
Biochim Biophys Acta. 2010 Jan;1803(1):55-71
pubmed: 20080133
Lancet. 2004 Sep 11-17;364(9438):937-52
pubmed: 15364185
Circulation. 1995 Sep 1;92(5):1355-74
pubmed: 7648691
Mediators Inflamm. 2020 Oct 6;2020:3872367
pubmed: 33082709
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Circulation. 2021 Feb 23;143(8):e254-e743
pubmed: 33501848
Circulation. 2015 Mar 31;131(13):1191-201
pubmed: 25712208
J Proteome Res. 2016 Apr 1;15(4):1116-25
pubmed: 26906401
Basic Res Cardiol. 2020 Nov 13;115(6):67
pubmed: 33185739

Auteurs

M Amin Sharifi (MA)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Michael Wierer (M)

Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany (M.W., M.M.).

Tan An Dang (TA)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Jelena Milic (J)

Division of Vascular Biology, Institute for Stroke and Dementia Research, Ludwig Maximilian University of Munich, Germany (J.M., J.B.).

Aldo Moggio (A)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).

Nadja Sachs (N)

Vascular Biology and Experimental Vascular Medicine Unit, Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University Munich, Germany (N.S., L.M.).

Moritz von Scheidt (M)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Julia Hinterdobler (J)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Philipp Müller (P)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Julia Werner (J)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Barbara Stiller (B)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).

Zouhair Aherrahrou (Z)

Institute for Cardiogenetics and University Heart Centre Lübeck, University of Lübeck, Germany (Z.A., J.E.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Hamburg/Kiel/Lübeck, Germany (Z.A., J.E.).

Jeanette Erdmann (J)

Institute for Cardiogenetics and University Heart Centre Lübeck, University of Lübeck, Germany (Z.A., J.E.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Hamburg/Kiel/Lübeck, Germany (Z.A., J.E.).

Andrea Zaliani (A)

Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).

Mira Graettinger (M)

Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).

Jeanette Reinshagen (J)

Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).

Sheraz Gul (S)

Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).

Philip Gribbon (P)

Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).
Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Hamburg, Germany (A.Z., M.G., J.R., S.G., P.G.).

Lars Maegdefessel (L)

German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).
Vascular Biology and Experimental Vascular Medicine Unit, Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University Munich, Germany (N.S., L.M.).

Jürgen Bernhagen (J)

German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).
Division of Vascular Biology, Institute for Stroke and Dementia Research, Ludwig Maximilian University of Munich, Germany (J.M., J.B.).

Hendrik B Sager (HB)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Matthias Mann (M)

Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany (M.W., M.M.).

Heribert Schunkert (H)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Thorsten Kessler (T)

Department of Cardiology, German Heart Centre Munich, Technical University of Munich, Germany (M.A.S., T.A.D., A.M., M.v.S., J.H., P.M., J.W., B.S., H.B.S., H.S., T.K.).
German Centre for Cardiovascular Research (DZHK e.V.), partner site Munich Heart Alliance, Germany (M.A.S., T.A.D., M.v.S., J.H., P.M., J.W., L.M., J.B., H.B.S., H.S., T.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH